IKZF1 and acute lymphoblastic leukemia: IKZF1 alterations are associated with poor outcome in both BCR-ABL1–positive and negative ALL cases, and triple the risk of treatment failure. IKZF1 status is an independent risk factor at a multivariable analysis of established prognostic factors.